Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) FCF Margin (2016 - 2025)

Historic FCF Margin for Dare Bioscience (DARE) over the last 9 years, with Q3 2025 value amounting to 12315.43%.

  • Dare Bioscience's FCF Margin rose 28139900.0% to 12315.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 11113.96%, marking a year-over-year increase of 116080100.0%. This contributed to the annual value of 47536.43% for FY2024, which is 489426800.0% up from last year.
  • Latest data reveals that Dare Bioscience reported FCF Margin of 12315.43% as of Q3 2025, which was up 28139900.0% from 26321.86% recorded in Q2 2025.
  • Dare Bioscience's 5-year FCF Margin high stood at 56241.46% for Q2 2024, and its period low was 73320.34% during Q1 2024.
  • For the 4-year period, Dare Bioscience's FCF Margin averaged around 4992.75%, with its median value being 4452.91% (2023).
  • Over the last 5 years, Dare Bioscience's FCF Margin had its largest YoY gain of 510710300bps in 2025, and its largest YoY loss of -299196000bps in 2025.
  • Dare Bioscience's FCF Margin (Quarter) stood at 84.49% in 2022, then tumbled by -475bps to 486.0% in 2023, then tumbled by -1568bps to 8106.22% in 2024, then plummeted by -52bps to 12315.43% in 2025.
  • Its last three reported values are 12315.43% in Q3 2025, 26321.86% for Q2 2025, and 22249.31% during Q1 2025.